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Approximately 20,000 stool specimens from patients 
with diarrhea visiting 1 urban and 1 rural hospital in Bangla-
desh during January 2001–May 2006 were tested for group 
A rotavirus antigen, and 4,712 (24.0%) were positive. G and 
P genotyping was performed on a subset of 10% of the posi-
tive samples (n = 471). During the 2001–2005 rotavirus sea-
sons, G1P[8] (36.4%) and G9P[8] (27.7%) were the domi-
nant strains, but G2[4] and G12P[6] were present in 15.4% 
and 3.1% of the rotavirus-positive patients, respectively. 
During the 2005–06 rotavirus season, G2P[4] (43.2%) ap-
peared as the most prevalent strain, and G12P[6] became a 
more prevalent strain (11.1%) during this season. Because 
recently licensed rotavirus vaccines include only the P[8] 
speciﬁ  city, it is unknown how the vaccines will perform in 
settings where non-P[8] types are prevalent.
G
roup A rotaviruses are the major etiologic agents of 
severe infantile diarrhea. Worldwide, >125 million in-
fants and young children develop rotavirus-associated diar-
rhea each year, resulting in 440,000 infant and child deaths, 
mostly in developing countries (1). In Bangladesh, rotavi-
ruses cause 6,000–14,000 deaths each year in children <5 
years of age (2). 
The tremendous incidence of rotavirus disease under-
scores the urgent need for interventions such as vaccines, 
particularly to prevent childhood deaths in developing na-
tions. Fortunately, 2 rotavirus vaccines, RotaTeq (Merck and 
Co., Whitehouse Station, NJ, USA) and RotaRix (Glaxo-
SmithKline, Research Triangle Park, NC, USA) passed a 
large safety trial, showed high efﬁ  cacy against the major 
rotavirus G types, and have been approved by the Food 
and Drug Administration (3,4). The efﬁ  cacy trials of these 
vaccines have been conducted in the United States, Latin 
America, and Europe but not in developing countries in Af-
rica and Asia.
Rotavirus infection shows a characteristic seasonal pat-
tern that is not clearly understood. In developed countries 
with temperate climates, peak incidence is in winter; how-
ever, in developing countries with tropical or subtropical 
climates, the virus circulates year-round (5–8). The temper-
ature in Bangladesh is usually high from April through Oc-
tober and relatively low from December through February. 
In addition, previous studies have indicated that rotavirus 
in Bangladesh is affected by ﬂ  oods, which increase oppor-
tunities for transmission of the virus (8,9). Bangladesh lies 
on the conﬂ  uence of hundreds of rivers and is inundated 
with water every year due to enhanced rainfall during the 
monsoon season, starting in June (10). 
Rotaviruses belong to the genus Reoviridae and consist 
of 11 segments of double-stranded RNA. Two outer capsid 
proteins, VP7 (deﬁ  ning G genotypes) and VP4 (deﬁ  ning 
P genotypes), independently elicit neutralizing responses. 
Based on these proteins, a dual classiﬁ  cation system of 
group A rotaviruses has been introduced (5). Rotaviruses 
can be serotyped by using neutralization assays with panels 
of antisera and genotyped by type-speciﬁ  c primer-depen-
dent reverse transcription–PCR (RT-PCR) and nucleotide 
sequence analysis (11–13). So far, >15 G and 26 P geno-
types have been described in humans and a variety of ani-
mals (6,14,15). The major human G types are G1, G2, G3, 
G4, and G9, which, combined with the P types P[8], P[4], 
and P[6], account for >80% of rotavirus-associated gastro-
enteritis episodes worldwide (16,17).
Rotaviruses show great genomic diversity, and several 
studies in different regions of Bangladesh have identiﬁ  ed 
types not targeted by candidate rotavirus vaccines (18–21). 
Unicomb et al. (8) showed that frequent genomic reassort-
ment among different rotavirus types was accelerated by 
mixed infection and generated huge genomic diversity. Al-
though the importance of type-speciﬁ  c immunologic pro-
tection against rotavirus disease is still under discussion, 
many investigators suggest that genomic characterization 
of rotaviruses is needed to assess whether vaccine efﬁ  cacy 
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might be altered by the changing pattern in the distribution 
of different G and P genotypes (17,22,23).
In our study, stool samples from gastroenteritis pa-
tients admitted to 2 hospitals, 1 urban and 1 rural, within 
the hospital surveillance system of International Centre 
for Diarrhoeal Disease Research, Bangladesh (ICDDR,B), 
from January 2001 through May 2006 were tested for the 
rotavirus VP6 antigen. The study objective was to clarify 
the genomic diversity of rotavirus in urban and rural areas 
in Bangladesh, with a goal of providing information for ro-
tavirus vaccine development programs.
Materials and Methods
Study Population
The ICDDR,B runs an urban hospital situated in Dha-
ka, the capital city of Bangladesh, which has a population 
of ≈10 million, and a rural hospital at Matlab, 45 km south-
east of Dhaka, which has ≈300,000 inhabitants. Each year, 
>100,000 patients are treated for diarrhea at the Dhaka 
hospital and ≈15,000 at the Matlab hospital. At the Dhaka 
hospital, diarrhea surveillance is conducted in a systematic 
manner; stool samples are collected to determine the pres-
ence of enteric pathogens in every 50th (2%) patient attend-
ing the hospital for treatment of diarrhea. In Matlab hospi-
tal, stool samples are collected from all patients from the 
community, which is under active rotavirus surveillance.
Rotavirus Antigen Detection
As part of the surveillance system, rotavirus antigens 
(group A rotavirus-speciﬁ  c VP6 proteins) were detected in 
the stool specimens using a solid-phase sandwich-type en-
zyme immunoassay modeled after the Dakopatts commer-
cial kit (Dakopatts, Copenhagen, Denmark), incorporating 
rabbit hyperimmune antisera produced at ICDDR,B and an 
anti-human rotavirus–horseradish peroxidase conjugate. 
The same criteria as those used by the Dakopatts kit were 
used for determination of positivity (8).
RNA Extraction
Rotavirus RNA was extracted from the stool samples. 
The QIAamp Viral RNA mini kit (Qiagen/Westburg, Leus-
den, the Netherlands) was used according to the manufac-
turer’s instructions
RT-PCR
A multiplex RT-PCR was performed by using the Qia-
gen OneStep RT-PCR Kit (Qiagen/Westburg) for rotavi-
rus G and P genotypes using type-speciﬁ  c oligonucleotide 
primers as previously described (Table 1) (11,13,24). The 
reaction was carried out with an initial reverse-transcription 
step at 45°C for 30 min, followed by 35 cycles of ampliﬁ  ca-
tion (30 sec at 94°C, 30 sec at 48°C, 1 min at 72°C), and a 
ﬁ  nal extension of 7 min at 72°C in a thermal cycler (Eppen-
dorf, Hamburg, Germany). PCR products were subjected to 
electrophoresis on a 2% agarose gel, stained with ethidium 
bromide, and observed under ultraviolet light. Speciﬁ  c seg-
ment sizes for different G and P genotypes were observed 
on the stained gel.
Nucleotide Sequencing
The PCR products were puriﬁ  ed with the QIAquick 
PCR puriﬁ  cation kit (Qiagen/Westburg) and sequenced by 
using the dideoxy-nucleotide chain termination method 
with the ABI PRISM BigDye Terminator Cycle Sequenc-
ing Reaction kit (Applied Biosystems, Foster City, CA, 
USA) on an automated sequencer. The consensus forward 
primer Beg9 and reverse primer End9 were used to am-
plify and sequence the VP7 gene. For the VP4 gene, the 
forward primer Con3 and reverse primer Con2 were used 
as described previously (11).Data Analysis and DNA Sequence Submission
Data were analyzed by SPSS for Windows, release 
11.5.1 (SPSS Inc., Chicago, IL, USA). The nucleotide se-
quence data of the rotavirus strains were submitted to the 
GenBank under the accession nos. DQ482712, DQ482718, 
DQ482725, DQ146652, DQ146653, DQ146654, DQ146-
658, DQ146663, DQ146664, DQ146665, DQ146669, 
EF033338, EF033339, and EF033340.
Results
Detection of Rotavirus Antigen
From January 2001 through May 2006, 19,039 stool 
specimens were tested for group A rotavirus VP6 antigen; 
4,644 (24.4%) samples had positive results. Table 2 shows 
the distribution of rotavirus-positive patients in the hospi-
tal surveillance systems in Dhaka and Matlab. The average 
detection rate of rotavirus was 25.2% in Dhaka and 23.3% 
in Matlab.
Quality Control
Stool specimens obtained from 311 patients with diar-
rhea were tested for the presence of rotavirus particles us-
ing the IDEIA rotavirus kit (DAKO Ltd., Cambridgeshire, 
UK). By using the IDEIA kit, 234 samples were found to 
be positive and 77 negative. By comparison, our in-house 
ELISA kit could detect rotavirus antigen in 232 of the IDE-
IA-positive samples. Among the IDEIA-negative samples, 
74 were negative for rotavirus antigen by our in-house kit. 
Thus, a comparison of the results indicated that our in-house 
ELISA kit had an overall sensitivity of 99.1% and speciﬁ  c-
ity of 96.1% compared with the IDEIA rotavirus kit.
Age of the Rotavirus-positive Patients
The age range of the rotavirus diarrhea patients (2001–
2005) was 1 month–63.2 years, median age 10 months, and 
mean age 22.8 months. Most of the rotavirus-positive pa-
tients (91%) were <2 years of age (Figure 1). Infection rates 
were lowest in patients <3 months and >5 years of age.
Seasonal Pattern of Rotavirus Infection
Figure 2 shows the monthly distribution of rotavirus 
diarrhea in Dhaka and Matlab. Rotaviruses were detected 
throughout the year in both settings, even though 2 clear 
seasonal rotavirus peaks were observed each year: a sharp 
winter peak in January and February, and a monsoon peak 
in July and August. Taking the average for each setting into 
account, our model suggests that the rotavirus season in 
Bangladesh usually starts in June and ends in May (year-
round).
Air temperature records for Dhaka and water level data 
for the Buriganga River (Sadarghat point, Dhaka) for the 
5 years of the study (2001–2005) were obtained from the 
Institute of Water Modelling, Dhaka, Bangladesh (www.
iwmbd.org). These data and the number of rotavirus pa-
tients admitted to the Dhaka hospital by month are shown 
in Figure 3. The temperature was lowest from December 
through February each year, which coincided with the in-
creased number of rotavirus diarrhea cases. On the other 
hand, the monsoon peaks of rotavirus diarrhea were cor-
related with the water level. The water level reached the 
highest mark during July–August each year, which corre-
sponded to the increase of the proportion of rotavirus diar-
rhea. The meteorologic data from Matlab also correlated to 
the increased incidence of rotavirus infection, as was seen 
for Dhaka (data not shown).
Distribution of G and P Types
G and P genotyping were carried out on 471 rotavirus 
antigen–positive stool samples (10% of all rotavirus-posi-
tive patients) by using a type-speciﬁ  c primer–based mul-
tiplex RT-PCR that could detect 6 G genotypes (G1, G2, 
G3, G4, G8, G9) and 5 P genotypes (P[8], P[4], P[6], P[9], 
P[11]). The untypeable and suspicious samples with lower 
amounts of PCR products were successfully typed and con-
ﬁ  rmed by using nucleotide sequencing. Table 3 shows the 
distribution of G and P types of rotavirus strains detected in 
Dhaka and Matlab. No signiﬁ  cant difference was observed 
between the distribution of rotavirus strains in Dhaka and 
Matlab (p>0.05). Overall, the most prevalent genotype was 
G1P[8] (33.8%), which was followed by G9P[8] (25.3%), 
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G2P[4] (20.2%), and G4P[8] (8.3%). Mixed infections 
were detected in 3.2% of the samples. Strains with unusual 
G-P combinations, such as G1P[6], G2P[6], and G2P[8], 
were also detected.
Unusual porcine-like G11 rotavirus strains were de-
tected in 3 patients (0.6%). These strains were untypeable 
by multiplex PCR because no G11-speciﬁ  c primer was 
included in the routine primer set. Therefore, sequencing 
of the VP7 and VP4 genes was required. The partial VP7 
gene sequences of the 3 G11 rotavirus strains (Dhaka22-01, 
Matlab36-02, and Dhaka13-06) were most similar (>98% 
similarities at the nucleotide and >97% at the amino acid 
level) to the porcine-like G11 strain Dhaka6 (15). On the 
other hand, the VP4 genes were most similar to human P[8] 
or P[6] strains (Malawi strain OP351, Thai strain 15vp4w, 
and US strain Se585).
Uncommon human G12 rotavirus strains (5.6%), 
were also detected during our study period. Because the 
G12 strains were untypeable by using our routine primers, 
nucleotide sequencing of their VP7 genes was required. All 
the VP7 gene sequences of the Bangladeshi G12 strains 
were most similar to the recently isolated G12 strains (In-
dian strain ISO-2) but distantly related to the prototype G12 
strain L26 isolated in the Philippines. The gene segments 
encoding the VP4, VP6, and NSP4 proteins were sequenced 
for Bangladeshi G12 strains Dhaka25-02 (G12P[8]) and 
Dhaka12-03 (G12P[6]). The VP4 gene sequence of strain 
Dhaka25-02 was most similar to the human P[8] rotavi-
rus strain DRC88 (98% similarity at the amino acid level) 
isolated in Democratic Republic of the Congo, and strain 
Dhaka12-03 was most similar to the human P[6] strain 
US1205 (99% similarity at the amino acid level) isolated 
in the United States. The VP6 and NSP4 sequences of both 
strains were also most similar to human rotavirus strains 
(Indian rotavirus strains RMC100, G25795, and V13520).
Polyacrylamide gel electrophoresis was performed for 
the 26 G12 strains isolated in our study, and 18 showed 
a clear RNA migration pattern. Long electropherotypes 
were detected in 15 (83.3%) samples, which included both 
G12P[8] and G12P[6] strains. Short electropherotypes were 
detected in only 3 (16.7%) samples, which also included 
both G12P[8] and G12P[6] strains.
Fluctuation of the G and P Types 
Distribution over Time
Large ﬂ  uctuations of the rotavirus genotype distribu-
tion were observed both in Dhaka and Matlab. However, no 
signiﬁ  cant difference was observed between the urban and 
rural setting with regard to the yearly distribution of geno-
types (p>0.05). The overall distribution of the major geno-
types over time is shown in Figure 4. The G1P[8] strains 
were less common in 2001, became the most predominant 
strains in the following years, but decreased again in 2005–
06. G9P[8] strains dominated in the ﬁ  rst 2 rotavirus seasons, 
decreased sharply during 2002–03, dominated again for the 
Figure 1. Age distribution for rotavirus-positive patients, Bangladesh, 
2001–2005.
Figure 2. Distribution of rotavirus-
positive patients by month, 
Dhaka and Matlab, Bangladesh. 
Percentages of positive rotavirus 
patients were calculated based 
on all diarrhea patients admitted 
to the Dhaka and Matlab hospital 
surveillance system during 
2001–2005. The years are shown 
with different colored lines. The 
thick brown line represents the 
average for all years.RESEARCH
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next 2 years, and decreased again during 2005–06. G4P[8], 
which had been the most prevalent strain in the 1990s in 
Bangladesh, was found to be less common in our study 
and constituted only 1.2% during 2005–06. Most interest-
ingly, the strain G2P[4] was the most predominant (43.2%) 
during the 2005–06 rotavirus season, although it was less 
common during the previous seasons (15.4% 2001–05). 
The uncommon strains G12P[6] and G12P[8], introduced 
in Bangladesh for the ﬁ  rst time during the 2000–01 sea-
son, became more prevalent (13.6%) in this region by the 
2005–06 season.
Discussion
Rotavirus was found in approximately one fourth of all 
patients with diarrhea who were treated at ICDDR,B hospi-
tals; most rotavirus cases (92.5%) occurred in children dur-
ing their ﬁ  rst 2 years of life. A recent report indicated that 
33% of children <5 years age admitted to the ICDDR,B 
from 1993 through 2004 were rotavirus positive (2). Re-
ports from other Asian countries also indicated that rotavi-
ruses were present in 20%–58% of patients with diarrhea 
who were <5 years of age. Thus, the rotavirus detection 
rate from our study is comparable to rates from some other 
Asian countries, including India, South Korea, and Hong 
Kong (20%–30%), but much lower than those reported in 
Taiwan, Thailand, China, Japan, Mayanmar, and Vietnam 
(43%–58%) (25–34).
Although rotavirus-associated diarrhea was document-
ed year-round in Dhaka and Matlab, a sharp winter peak and 
a monsoon peak were observed each year. The winter rota-
virus peak is usually observed worldwide, but the monsoon 
peak is not common in settings with temperate climates. 
We analyzed environmental data including rainfall and wa-
ter level of the nearest river and found that the monsoon ro-
tavirus peaks in Bangladesh could be deﬁ  ned by high water 
levels due to heavy rainfall, which normally starts in the 
second week of June (35). Because of the heavy rainfall, 
the water level of the rivers begins to increase and reaches 
its highest level during July–August each year, resulting 
in inundation of the surrounding areas and increasing the 
chance of fecal contamination of water. Ahmed and col-
leagues reported that the number of rotavirus diarrhea cases 
increased remarkably, and mixed rotavirus types were fre-
quently isolated during the ﬂ  oods in 1988 in Dhaka (10). In 
July and August 2004 in Matlab (Figure 2), a large increase 
in rotavirus-associated diarrhea was observed. Analysis of 
the water level of the nearest river (Chandpur point of the 
Meghna River, data not shown) showed that this increase 
correlated directly with an increased water level. The water 
level reached the 5.42 meter mark in July 2004, the highest 
in that region during our study period.
Our main goal was to characterize the VP7 (G geno-
type) and VP4 (P genotype) gene segments of the rotavirus 
strains. We identiﬁ  ed most of the globally common rotavi-
rus types (G1, G2, G4, and G9) in our study. Surprisingly, 
no G3 strain has been detected in Bangladesh since 1993, 
even though G3 is one of the most prevalent rotavirus types 
worldwide (8,25,29). Results of rotavirus diversity from this 
Figure 3. Correlation between cases of rotavirus diarrhea and air 
temperature (A) and water level (B) in Dhaka, Bangladesh, January 
2001–May 2005.G2P[4] and G12P[6] Rotavirus, Bangladesh
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study were compared with previous ﬁ  ndings in Bangladesh 
(8), and we observed that the distribution of rotavirus geno-
types was changing over time. From 1992 through 1997, 
the most common rotavirus genotype was G4 (47% of the 
typeable rotavirus strains), but this genotype’s prevalence 
gradually decreased, and it became a less common rotavi-
rus strain over time (1.2% in 2005–06). The distribution of 
G2 strains, on the other hand, remained nearly unchanged 
through rotavirus season 2004–05 (19.5% in 1992–1997 
and 16.2% in 2001–2005). However, G2 suddenly became 
the most prevalent genotype in 2005–06 (43.2%).
Three G11 strains, commonly found in pigs, were iso-
lated from humans in the present study. In Bangladesh, pigs 
are uncommon farm animals, and no genotyping studies on 
pigs or other animals have been conducted. Therefore, the 
identiﬁ  cation of the strains with an animal-like G11 VP7 
speciﬁ  city and a human P[8] or P[6] speciﬁ  city raises the 
question whether these strains are reassortants of human 
and animal rotavirus strains. This ﬁ  nding underscores the 
need to include animal rotavirus strains rotavirus surveil-
lance programs. At the same time, water samples, particu-
larly those collected during ﬂ  oods, can be evaluated for the 
presence of unusual rotavirus strains that might have been 
introduced from domestic animals.
For the ﬁ  rst time in Bangladesh, a very uncommon hu-
man rotavirus strain, G12, was detected. The strain was ﬁ  rst 
detected in 1987–1988 in the Philippines, and since then, it 
has been emerging all over the world (36–40). G12 is re-
ported as an important rotavirus strain in India (17.1% in 
2003–2005) and in Argentina (6% in 1999–2003) (17,36). 
A considerable proportion of G12 was also documented 
during our study period and reached 13.6% in the latest 
rotavirus season (2005–06). Thus, the emergence of G12 
strains has led to the need for prospective surveillance us-
ing new diagnostic RT-PCR primers for G12 strains.
Genetic analysis of the VP4, VP6, and NSP4 gene seg-
ments showed that the Bangladeshi G12 strains contained 
typical human rotavirus gene segments distantly related to 
the prototype G12 strains L26 and T152. It is possible that 
the VP7 gene segments from the prototype G12 strains were 
reassorted with the typical human rotavirus strains. More 
genetic analyses of complete genome sequences would be 
helpful to investigate the possible reassortment events and 
evolution of the recently emerging G12 strains.
P genotype analysis showed that the rotavirus strains 
with the P[8] speciﬁ  city made up 76.4% of the circulat-
ing strains during 2001–2005; non-P[8] strains constitut-
ed 21.9%. The most interesting ﬁ  nding about P types in 
our study was that the non-P[8] strains represented more 
than half of the strains (56.8%) during the rotavirus season 
2005–06. The currently licensed rotavirus vaccines have 
shown high efﬁ  cacy rates in trials and have focused on the 
role of the major G genotypes, but the role of P genotypes 
has not been addressed clearly (3,4). These vaccines include 
the P[8] speciﬁ  city, but it is unknown how the vaccines will 
perform in settings where the non-P[8] types are prevalent. 
An efﬁ  cacy trial of the rotavirus vaccine RotaTeq will begin 
soon in Bangladesh, so the ﬁ  ndings of our study regarding 
rotavirus strain diversity will be important for evaluating 
the results of this trial.
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